Tumor angiogenesis is a hallmark of cancer that has been identified as a critical component of cancer progression, facilitating rapid tumor growth and metastasis.
The generation and release of fragmented molecules could generate novel biochemical markers with the capacity to monitor disease progression, facilitate drug development and add to the existing toolbox for in vitro studies, preclinical research and clinical trials.
It is possible that miR-200 levels are differentially regulated at different times in tumor progression, facilitating distinct outcomes.
E-cadherin down-regulation is apparently important in cancer progression, facilitating cell detachment and metastasis.
This process generates several 5′ ends primer-template junctions, as it is the case for normal fork progression, facilitating the binding of the 9-1-1 complex.
Similar comparative analysis of cancer cell phylogenies could reveal which molecular changes occurring during neoplastic progression facilitate the development of invasive, metastatic and resistant cell phenotypes.
Furthermore, improved analytical measurement sensitivity may offer tools to detect and quantify disease markers at earlier stages of progression, facilitating more timely treatment and improved outcome.
Resistance to apoptosis plays a critical role during tumorigenesis and tumour progression, facilitating the accumulation of transforming mutations, promoting evasion of tumour cells from immunosurveillance and contributing to resistance against anticancer drugs (Gerharz et al, 1999; Reed, 1999; Ramp et al, 2000, 2003a, 2003b; Igney and Krammer, 2002).
The strong association of tumour classification with metastatic progression facilitates molecular prognostic testing of patients by either chromosome 3 testing or GEP, and studies have shown that the majority of patients want to know their risk of developing metastasis even though no treatment options currently exist (Beran et al, 2009; Damato and Coupland, 2009).
This article considers a mathematical model for tumour growth based on an acid-mediated hypothesis, i.e. the assumption that tumour progression is facilitated by acidification of the region around the tumour-host interface.
